MeiraGTx Holdings plc Depreciation
MeiraGTx Holdings plc (MGTX) reported Depreciation of $7.30 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-03-14
- MeiraGTx Holdings plc depreciation for the quarter ending 2020-12-31 was $879.14K, a 31.32% increase year-over-year.
- MeiraGTx Holdings plc depreciation for the quarter ending 2020-09-30 was $1.07M, a 99.90% increase year-over-year.
- MeiraGTx Holdings plc depreciation for the quarter ending 2020-06-30 was $940.32K, a 75.22% increase year-over-year.
- MeiraGTx Holdings plc depreciation for the quarter ending 2020-03-31 was $815.42K, a 63.20% increase year-over-year.
- MeiraGTx Holdings plc depreciation for fiscal 2022 was $7.30M, a 15.87% increase from fiscal 2021.
- MeiraGTx Holdings plc depreciation for fiscal 2021 was $6.30M, a 70.27% increase from fiscal 2020.
- MeiraGTx Holdings plc depreciation for fiscal 2020 was $3.70M, a 65.28% increase from fiscal 2019.
- MeiraGTx Holdings plc depreciation for fiscal 2019 was $2.24M, a 9.03% increase from fiscal 2018.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $7.30M 10-K · filed 2023-03-14 | ||||
| 2021-12-31 | $6.30M 10-K · filed 2023-03-14 | ||||
| 2020-12-31 | $879.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.94M derived: sum of 2 quarters · filed 2022-03-10 | $2.88M derived: sum of 3 quarters · filed 2022-03-10 | $3.70M 10-K · filed 2022-03-10 | $4.17M 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.01M derived: sum of 2 quarters · filed 2020-11-05 | $2.82M 10-Q · filed 2020-11-05 | $3.49M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2020-06-30 | $940.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.76M 10-Q · filed 2020-08-06 | $2.43M derived: sum of 3 quarters · filed 2021-03-11 | $2.96M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2020-03-31 | $815.42K 10-Q · filed 2020-05-07 | $1.48M derived: sum of 2 quarters · filed 2021-03-11 | $2.02M derived: sum of 3 quarters · filed 2021-03-11 | $2.55M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-12-31 | $669.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.20M derived: sum of 2 quarters · filed 2021-03-11 | $1.74M derived: sum of 3 quarters · filed 2021-03-11 | $2.24M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $532.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.07M derived: sum of 2 quarters · filed 2020-11-05 | $1.57M 10-Q · filed 2020-11-05 | $2.07M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $536.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.04M 10-Q · filed 2020-08-06 | $1.54M derived: sum of 3 quarters · filed 2020-08-06 | $2.07M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $499.64K 10-Q · filed 2020-05-07 | $1.00M derived: sum of 2 quarters · filed 2020-05-07 | $1.54M derived: sum of 3 quarters · filed 2020-05-07 | $2.09M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $503.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.04M derived: sum of 2 quarters · filed 2020-03-11 | $1.59M derived: sum of 3 quarters · filed 2020-03-11 | $2.05M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $534.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.09M derived: sum of 2 quarters · filed 2019-11-07 | $1.55M 10-Q · filed 2019-11-07 | $1.65M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $556.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.02M 10-Q · filed 2019-08-07 | $1.11M derived: sum of 3 quarters · filed 2019-08-07 | $1.32M derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | $458.84K 10-Q · filed 2019-05-14 | $558.32K derived: sum of 2 quarters · filed 2019-05-14 | $764.74K derived: sum of 3 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $99.48K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $305.90K derived: sum of 2 quarters · filed 2019-03-26 | $679.18K 10-K · filed 2019-03-26 | ||
| 2017-09-30 | $206.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $579.70K 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $373.28K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |